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Abstract
Background: Cardiac dysfunction is a common complication associated with major burns. While recent findings
have linked the Th-17 T-cell response to the development of autoimmune myocarditis, the role of IL-17 and the
Th-17 T-cell response in the development of post-burn cardiac dysfunction remains unknown.
Methods: Male C57BL/6 mice were subjected to a major burn (3rd degree, 25% TBSA) or sham treatment. Three
hours after injury plasma and tissue (i.e., heart, lung, liver, small intestine) samples were collected and analyzed for
the expression of Th-17 cytokine (i.e., IL-6, IL-17, IL-22, IL-23, TGF-b) levels by ELISA.
Results: Cardiac tissue levels of the Th-17 cytokines, IL-6, IL-17 and IL-22 were significantly elevated at 3 hrs after
burn as compared to sham levels. IL-17 was analyzed 1, 3 and 7 days after burn and showed a return to baseline
levels and without a difference in the burn group. Burn-induced alterations in the level of these cytokines in
plasma or other tissues were not evident. The cardiac Th-17 cytokine response after burn injury was specific, as
cardiac levels of Th-1 (IFN-g) and Th-2 (IL-10) cytokines were not significantly affected after injury. The cardiac Th-17
response correlated with a significant increase in Troponin levels at 3 hr. after burn.
Conclusion: These findings indicate that early after burn, cardiac tissue is associated with significantly elevated
levels of Th-17 cytokines. The early Th-17 response after burn appears to be specific for cardiac tissue and may
promote myocardial inflammation and dysfunction associated with this form of trauma.
Background
Burn injury initiates changes in the immune function
that result in local and systemic inflammation that can
lead to life-threatening end-organ dysfunction. Cardiac
dysfunction after burn has been well described and has
been shown to play an important role in patient out-
come [1]. Several studies have been conducted to
explain the pathways involved in myocardial dysfunction
after burn since the early studies of Blalock in the
1930’s [2]. Excessive production of pro-inflammatory
cytokines, interleukin (IL)-6 IL-1b and tumor necrosis
factor-a (TNF-a) have been associated with the cardiac
cell damage [3]. Studies have shown differences in the
cytokine expression profile in severely burned patients
and in the magnitude of the systemic and compartmen-
tal inflammatory response correlated with progressive
left ventricular contraction and relaxation defects,
achieving a nadir with 40% of TBSA burn [3,4]. While
studies have implicated cardiomyocytes as a cellular
source of pro-inflammatory cytokines after burn, other
cell populations are also clearly important [5,6].
Recently a novel class of T-helper cells, called Th-17
cells, has been found to secrete the pro-inflammatory
cytokine IL-17 [7]. This recently discovered cytokine
appears to play an important role in inflammation and
autoimmunity. Moreover, in addition to IL-17, other
cytokines such as IL-6 and TGF-b, normally associated
with inflammation, are also associated with Th-17 cells.
In this regard, the Th-17 response has been recently
implicated in the response to several models of infection
[8]. This suggests that the Th-17 response may be
important in the inflammatory response after burn.
The importance of cardiomyocyte injury after burn
has been emphasized in recent years, however, its patho-
genesis, has not been fully clarified. In the current study
we examined the role of the Th-17 mediated inflamma-
tory response in the development of the cardiac injury
after burn in a mouse model.
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Methods
Animals
C57BL/6 male mice (18 to 22 g; 8 to 10 wk of age,
Charles River Laboratories, Wilmington, MA) were used
for all experiments. The mice were allowed to acclima-
tize in the animal facility for at least 1 week prior to
experimentation. Animals were randomly assigned into
either a thermal injury group or a sham treatment
group. The experiments in this study were approved by
the Institutional Animal Care and Use Committee of
the University of Texas Health Science Center at San
Antonio, and were performed in accordance with the
National Institutes of Health guidelines for the care and
handling of laboratory animals.
Thermal injury procedure
Mice received a scald burn as described previously [9].
Briefly, the mice were anesthetized by intraperitoneal
(IP) injection of ketamine/xylazine, and the dorsal sur-
face was shaved. The anesthetized mouse was placed in
a custom insulated mold exposing 12.5% of their total
body surface area (TBSA) along the right dorsum. The
mold was immersed in 70°C water for 10 sec to produce
a 3rd degree burn. The burn procedure was repeated on
the left dorsum yielding a total burn size of 25% TBSA.
The mice were then resuscitated with 1 ml of Ringer’s
lactate solution administered by intraperitoneal injection
and returned to their cages. The cages were placed on a
heating pad for 2 hr until the mice were fully awake, at
which time they were returned to the animal facility.
Sham treatment consisted of anesthesia and resuscita-
tion with Ringer’s lactate solution only.
Tissue collection and processing
At 3 hr after injury the mice were euthanized and tissue
samples collected (plasma, heart, lung, liver, and small
intestine). The tissue samples were snap frozen in liquid
nitrogen and stored at -80°C prior to analysis.
Cytokine, Troponin-I, Myleoperoxidase and HMGB-1
determinations
Tissue samples were homogenized in protease inhibitor
cocktail as previously described prior to analysis [10].
Plasma samples were not treated. Tissue levels of Th-17
(IL-6, IL-17, IL-22, IL-23, TGF-b) Th-1 (IFN-g), and
Th-2 (IL-10) cytokines were determined by ELISA
according to the manufacturer’s recommendations(R&D
Systems) Plasma cardiac specific Troponin-I, HMGB-1
levels and cardiac myleoperoxidase (MPO) levels were
determined by ELISA similarly, (Genway, Shino-Test
Corp, Hycult biotechnology). Values obtained were nor-
malized to total protein of the tissue homogenate as
determined by BCA assay.
Statistical analysis
Data are expressed as mean ± SE. Comparisons were
analyzed using ANOVA. A P value of < 0.05 was con-
sidered to be statistically significant for all analyses.
Results
Burn induces an increased Th-17 response in the
heart at 3 hours after injury
Sham and burn groups were composed of 6 and 5 ani-
mals, respectively. There were no animal deaths after
burn or sham procedures. At 3 hrs, 1 day, 3 days and 7
days after the burn or sham treatment, animals were
euthanized and the heart removed. As shown in figure
1, burn caused a significant (P < 0.05) elevation in the
cardiac levels of IL-17, 3 hours after injury as compared
to the sham animals. One day after burn, IL-17
remained elevated, however, without significant differ-
ence from the respective sham group. Sham levels of
IL-17 were significantly (P < 0.05) greater at 3 hrs and
1 day as compared with days 3 and 7. This early cyto-
kine response is likely related to volume loading early
after resuscitation, as both sham and burn mice received
resuscitation fluid. Based on the observation that the
IL-17 response was significantly higher at 3 hrs after
burn, all subsequent analysis was conducted on that
group of animals.
In addition to IL-17, we analyzed the heart for the
Th-17 family cytokines IL-6, IL-22, IL-23 and TGF-b.
As shown in figure 2, burn induced an early myocardial
inflammation as evidenced by significantly higher (P <
0.05) levels of IL-17, IL-6 and IL-22 in the burn group
as compared to the sham animals. The TGF-b response
was not different between groups and IL-23 was vir-
tually undetectable in cardiac tissue samples.
We also investigated the effects of burn in other tis-
sues at 3 hrs after injury. Table 1 summarizes the find-
ings for plasma, liver, lung and small intestine. In
Figure 1 Cardiac IL-17: Cardiac tissue at 3 hrs, 1 day, 3 days
and 7 days was assessed for IL-17 content as described in the
Materials and methods. Data are mean ± SE for 5-6 mice/group.
*P < 0.05 as compared to sham.
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contrast to the cardiac response, no significant differ-
ences were found in those tissues with regard to IL-6,
IL-17 and IL-22 levels.
Burn induces heart injury at 3 hours after burn
We found that burn was associated with increased Tro-
ponin-I levels at 3 hours after injury (Fig. 3A), indicating
cardiomyocyte damage. At 24 hours after the burn, the
Troponin-I levels began to normalize and did not differ
from those of the uninjured animal (data not shown).
Plasma levels of the early inflammatory marker HMGB-1
were not elevated at 3 hrs (Fig 3B). To elucidate the role
of neutrophils in the early cardiac injury after burn, we
analyzed heart tissue for MPO levels. As shown in
Fig. 3C., MPO levels were unchanged in the burn group
as compared to the sham animals at 3 hours after burn.
Histologic analysis indicated no major changes in cardiac
morphology at 3 hrs after burn (data not shown.)
Burn induced cardiac cytokine response is Th-17 specific
To determine whether the cytokine response in the
heart after burn was also related to changes in the Th1
and Th2 we analyzed heart tissue for IFN-g or IL-10 as
specific markers of the Th1 and Th2 response respec-
tively. IFN-g was not detectable irrespectively of the
group and IL-10 levels were similar in sham and burned
animals at 3 hrs after injury. (Table 2)
Discussion
The inflammatory cascade elicited by burn activates a
broad immunoinflammatory response known as the Sys-
temic Inflammatory Response Syndrome (SIRS). This
response involves a wide range of cells (e.g, macro-
phages, T-cells, neutrophils) and tissues (e.g., skin,
spleen, liver, cardiac, lung). Ultimately, SIRS increases
the potential for the development of Multiple Organ
Dysfunction Syndrome (MODS). Since the initial studies
of Blalock in the 1930’s about cardiovascular impair-
ment after burn, many models have been proposed to
explain its pathophysiology including fluid shift, changes
in the microcirculation, coagulopathy and peripheral
vasoconstriction, however, the most recent research stu-
dies have been focused on the association of certain fac-
tors with the cardiac dysfunction after burns, including
complement, cellular apoptosis and cytokines as the
purpose of the current study [2,11-14]. The pathophy-
siologic response in the cardiovascular system includes
myocardial contractile dysfunction and increased vascu-
lar permeability. Several studies have shown that cardiac
depression associated to burn injuries occurs indepen-
dently of the plasma loss, develops early after the injury
and early large volume resuscitation does not affect
morbidity or mortality, suggesting an intrinsic tissue
Figure 2 Cardiac Th-17 Cytokines: Cardiac tissue at 3 hrs after
burn or sham procedure was assessed for content of Th-17
cytokines as described in the Materials and Methods. Data are
mean ± SE for 5-6 mice/group. Data shown for IL-17 is the same as
that shown for IL-17 at 3 hrs in Fig.1 and is included for
comparative purposes. *P < 0.05 as compared to sham.
Table 1 Tissue levels of IL-6, IL-17 and IL-22.
Plasma Lung Liver S.I.
IL-17 Sham n/d 175 ± 60 421 ± 96 19 ± 13
Burn n/d 133 ± 60 309 ± 63 18 ± 14
IL-6 Sham n/d 72 ± 20 103 ± 15 4 ± 3
Burn n/d 53 ± 8 70 ± 15 4 ± 3
IL-22 Sham n/d 50 ± 17 66 ± 5 6 ± 2
Burn n/d 20 ± 3 59 ± 7 5 ± 2
Plasma, lung, liver and small intestine levels of IL-17, IL-6 and IL-22 were
determined as described in Materials and Methods. Samples of sham and burn
mice were collected 3 hrs after burn or sham procedure. Data are mean ± SE;
n = 6 mice/group. No significant differences were found on those tissues in the
burn group compared to the sham animals. n/d = not detectable
Figure 3 Cardiac MPO and plasma Troponin and HMGB-1 levels:
At 3 hrs after burn and sham, plasma Troponin (A) and plasma
HMGB-1 (B) and cardiac MPO (C) levels were assessed as
described in the Materials and Methods. Data are mean ± SE for
5-6 mice/group. *P < 0.05 as compared to sham.
Table 2 Cardiac levels of IFN-g and IL-10
Sham Burn
IL-10 87 ± 25 133 ± 28
IFN-g n/d n/d
Cardiac levels of IL-10 and IFN-g were determined 3 hrs after burn or sham
procedure as described in the Materials and Methods. Data are mean ± SE;
n = 6 mice/group. IFN-g was not detectable irrespectively of the group and
IL-10 levels were similar in sham and burn mice. n/d = not detectable.
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damage as a cause of its failure [2,15,16]. Studies have
confirmed the cardiovascular function impairment is in
part a consequence of increased generation of poten-
tially harmful mediators such as pro-inflammatory cyto-
kines in models of myocardial ischemia, burn and sepsis
[17,18]. Studies done by Barber et al, have pointed to
cardiomyocytes as the source of those cytokines [3].
This study by Barber et al. also showed a correlation of
the burn size and the cytokine response and the degree
of left ventricular dysfunction to a nadir of 40% TBSA.
Maass et al. showed a synergistic effect of IL-1b, Il-6
and TNF-a exacerbating cardiac contraction and
relaxation deficits produced by any one inflammatory
cytokine [17].
Studies by Finnerty et al. have recently shown that cir-
culating IL-17 levels are increased early after burn in
pediatric patients, as well in a mouse burn model
[19,20]. These initial findings are suggestive that IL-17
plays an important role in the inflammatory response
after burn. In that regard, results from the present study
demonstrate that the early cardiac inflammatory
response after burn involves IL-17 and other Th-17
cytokines (IL-6, IL-22). This cardiac Th-17 response
correlated with the development of cardiac injury, as
reflected in elevated plasma levels of Troponin-I, a sen-
sitive and specific marker of myocardial injury after
burn, correlating with cardiac contraction and relaxation
deficits [21]. Huang et al. also showed a significant
increase in serum levels of Troponin-I at 3 hours after
burn [15]. Somewhat surprisingly elevated levels of car-
diac IL-17 were observed in sham animals at 3 and 6
hrs. This apparently aberrant response may be related to
volume loading due to the administration of 1 ml IP of
Ringer’s lactate to the sham mice. This concept is sup-
ported by the observation that by 1 day once fluid levels
have normalized IL-17 levels are barely detectable in the
sham mice. In our study, the Th-17 response at 3 hr
was organ specific as other tissues (lung, liver and small
intestine) did not show a significant change in the Th-
17 response. This does not preclude the possibility that
other tissues express a Th-17 response later after injury.
The recruitment of immune cells, particularly neutro-
phils, to a site of injury is the initial step in most inflam-
matory processes. Activated neutrophils release
proteases and reactive oxygen intermediates, which can
lead to significant tissue damage [22]. Recent studies by
Abdel-Rahman showed that limiting neutrophils activity
after cardiopulmonary bypass, improves perioperative
hemodynamics and cardiac function, demonstrating its
detrimental effects upon activation [23]. We have shown
that the cardiac Th-17 response at 3 hr. post-burn is
not associated with neutrophils infiltration as evidenced
with unchanged levels of cardiac tissue MPO. A change
in circulating levels of the HMGB-1 was also not
evident in the current study. This may be in part related
to the early time after injury that was investigated or the
severity of the burn.
Evidence points to IL-17 as the major effector mole-
cule produced by Th-17 cells. IL-17 stimulates several
cell types, such as endothelial cells, epithelial cells and
macrophages to produce multiple pro-inflammatory
mediators, including IL-6 and IL-23 [24]. It also stimu-
lates the mobilization and de novo generation of neutro-
phils by granulocyte-colony stimulating factor (G-CSF),
thereby bridging a gap between innate and adaptive
immunity and might constitute an early defense
mechanism against severe sepsis [25]. Th-17-driven
effector functions may also be different in different tis-
sues [7]. We found that cardiac Th cytokine responses
after burn were specific for Th-17, as cardiac levels of
Th-1 (IFN-g) and Th-2 (IL-10) cytokines were not sig-
nificantly affected by burn. IL-17 is thought of as a
T-cell derived cytokine, however, limited studies suggest
to non T-cell cell types can also produce this cytokine.
Recent study by Lapara NJ 3rd et al. showed that
macrophages are the key source of inflammatory media-
tors in Leishmania infection [26]. Studies have also
shown increased IL-17-expressing macrophages in active
inflammatory bowel disease, high expression of IL-17 in
macrophages-mediated inflammatory response in breast
cancer as a promoter of invasiveness, and increased pro-
duction in astrocytes and oligodendrocytes in patients
with active multiple sclerosis [27-29]. Thus, the concept
that cardiomyocytes can produce IL-17 directly is plau-
sible. Future studies will need to examine the ability of
isolated cardiomyocytes to produce IL-17 in vitro to
validate this concept.
Conclusion
Interventions in the complex inflammatory cascade fol-
lowing burn might improve morbidity and mortality in
this patient population. These initial findings suggest
that IL-17 may provide a unique target of therapeutic
intervention to reduce cardiac dysfunction after burn.
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